Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Masitinib for the Treatment of Severe Mast Cell Activation Syndrome - Drug Trials For Money - Paid Clinical Trials

Masitinib for the Treatment of Severe Mast Cell Activation Syndrome

Masitinib for the Treatment of Severe Mast Cell Activation Syndrome
Condition:   Mast Cell Activation Syndrome
Interventions:   Drug: Masitinib 4.5 mg/kg/day;   Drug: Placebo;   Other: Best supportive care;   Drug: Masitinib 6.0 mg/kg/day
Sponsor:   AB Science
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 9, 2022 / by / in
Comments